Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study

This publication has 30 references indexed in Scilit:

• Nelfinavir
  Drugs, 2000
• Transport, metabolism and elimination mechanisms of anti-HIV agents
  Advanced Drug Delivery Reviews, 1999
• Hepatobiliary and intestinal clearance of amphiphilic cationic drugs in mice in which bothmdr1aandmdr1bgenes have been disrupted
  British Journal of Pharmacology, 1998
• The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.
  Journal of Clinical Investigation, 1998
• PCR-based genotyping for duplicated and deleted CYP2D6 genes
  Pharmacogenetics, 1996
• P-glycoprotein: a major determinant of rifampicin-inducible expression of cytochrome P4503A in mice and humans.
  Proceedings of the National Academy of Sciences, 1996
• Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.
  Journal of Clinical Investigation, 1995
• Multidrug transporter p‐glycoprotein 170 as a differentiation antigen on normal human lymphocytes and thymocytes: Modulation with differentiation stage and during aging
  American Journal of Hematology, 1995
• Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells
  Cell, 1991
• Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification
  The Lancet, 1990